A company can begin to determine its product’s habit-forming potential by plotting two factors: frequency (how often the behaviour occurs) and perceived utility (how useful and rewarding the behaviour is in the user’s mind over alternative solutions. A behaviour that occurs with enough frequency and perceived utility enters The Habit Zone, helping to make it a default behaviour. If either of these factors falls short and the behaviour lies below the threshold, it is less likely that the desired behaviour will become a habit. Some behaviours will never become habits because they do not occur frequently enough. On the other hand, even a behaviour that provides minimal perceived benefit can become a habit simply because it occurs frequently.
These habits are good for a business because it increases customer lifetime value, amount of money made from a customer before that person switches to a competitor. It can provide pricing flexibility, as customers form routines around a product, they come to depend on it and become less sensitive to price. User habits are a competitive advantage. Products that change customer routines are less susceptible to attacks from other companies.
One aspect is common to all successful innovations = they solve problems. Investors want to invest in painkillers — as they solve an obvious need, relieving a specific pain, and often have quantifiable markets. Vitamins, by contrast, do not necessarily solve an obvious pain point. Instead they appeal to users’ emotional rather than functional needs. What about social media? Many people would say they are selling vitamins as their users are not doing anything particularly important than perhaps seeking a quick boost of social validation. However, consider this idea: a habit is when not doing an action causes a bit of pain. Habit-forming technologies are both vitamins and painkillers. They are at first offering nice-to-have vitamins, but once the habit is established, they provide an ongoing pain remedy.